Genetic polymorphisms in the mevalonate pathway affect the therapeutic response to alendronate treatment in postmenopausal Chinese women with low bone mineral density

PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses

Shaun Purcell, Benjamin M. Neale, Katherine EO Todd-Brown et al. · The American Journal of Human Genetics · 2007 · 36.1K citations · Full text

Life Sciences, Bioinformatics, Genetics +13

Clinician’s Guide to Prevention and Treatment of Osteoporosis

Felicia Cosman, Suzanne M. Jan de Beur, Meryl S. LeBoff et al. · Osteoporosis International · 2014 · 4.1K citations · Full text

Medicine, Orthopedic Surgery, Pharmacotherapy +16

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

J. A. Kanis, E. V. McCloskey, Håkan Johansson et al. · Osteoporosis International · 2012 · 2.9K citations · Full text

Medicine, Endocrinology, Orthopedic Surgery +17

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

Uri Liberman, Stuart Weiss, Johann Bröll et al. · New England Journal of Medicine · 1995 · 2.3K citations

Medicine, Endocrinology, Bone Metabolism +14

Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>

S. R. Cummings · JAMA · 1998 · 2.3K citations

Medicine, Endocrinology, Bone Augmentation +16